Ignite Creation Date:
2024-05-05 @ 9:36 PM
Last Modification Date:
2024-10-26 @ 10:07 AM
Study NCT ID:
NCT00929084
Status:
COMPLETED
Last Update Posted:
2019-08-26
First Post:
2009-06-24
Brief Title:
Survivor Stories Impact on Cancer Patients Quality of Life and Follow-up
Sponsor:
Washington University School of Medicine
Organization:
Washington University School of Medicine
Study Overview
Official Title:
Survivor Stories Impact on Cancer Patients Quality of Life and Follow-up
Status:
COMPLETED
Status Verified Date:
2019-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to evaluate in a randomized controlled trail an innovative cancer communication strategy to help African American breast cancer patients cope with a variety of challenges during and after treatment and to better adhere to recommended treatment guidelines and follow-up care
Detailed Description:
Disparities in incidence and mortality between African Americans and Caucasians for a number of cancers have been well documented This study builds on previous work in St Louis to overcome barriers to access to breast screening identifying and addressing factors associated with access to care once diagnosed and factors contributing to delay in diagnosis and completion of therapy African American breast cancer patients randomly assigned to the intervention arm of the trial will have access to the Survivor Stories Tablet a tablet computer on which they will browse an archive of 1-3 minute videotaped survivor stories about five topics coping relationships experiences with the health care system follow-up care and quality of life QOL living with breast cancer Patients will have the tablet for two weeks after enrollment in the study and again at 6 and 12 months Patients in the control arm will receive usual care
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None